Samuel Allemann

Has grant

Assistant Professor

University of Basel

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

ORCID

Google Scholar

Academic Page

About

Dr. Samuel Allemann is an Assistant Professor at the University of Basel, Switzerland. His research focuses on pharmacogenetics, including the enablers of pharmacogenetic-informed treatment decisions, strategies for pharmacist-led services, and the clinical relevance of medication management. Recent articles highlight his work on patient adherence to antiseizure medications, barriers to hepatitis C treatment, and the implementation of new adherence monitoring systems.

Recent Grants

Grant: Close

myCare Start - Support at the beginning of chronic treatment in the pharmacy to promote therapeutic success: A feasibility study

Open Date: 2019-10-01

Close Date: 2020-07-01

Grant: Close

A reproducible method to analyze and predict adherence to polypharmacy from electronic healthcare data

Open Date: 2018-03-01

Close Date: 2019-08-31

Samuel Allemann

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (19)

Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions—A Longitudinal Mixed-Methods Study Exploring the Patient Perspective

Clinical relevance and implementation into daily practice of pharmacist-prescribed medication for the management of minor ailments

Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical Practice

Initiation of oral hepatitis C virus treatment: Which barriers are pertinent for ambulatory individuals with a history of illicit substance use? A qualitative interview study

Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy

Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study

Adherence patterns in antiseizure medications influencing risk of sudden unexplained death in epilepsy: A data linkage study using dispensed prescriptions

Development and acceptance of a new adherence monitoring package to identify non-adherent patients with polypharmacy in primary care: a feasibility study

Knowledge and attitudes of German and Swiss community pharmacists towards biologicals and biosimilars – a prospective survey before and after the COVID-19 pandemic

Non-adherence and epileptic emergency—reasons and solutions,Ungenügende Adhärenz als Grund für epileptische Anfälle – Mechanismen und Lösungsansätze

Development of a Protocol Using the Delphi Method for the ad interim Supply of Hormonal Contraceptives in Swiss Pharmacies

Swiss Priority Setting on Implementing Medication Adherence Interventions as Part of the European ENABLE COST Action.

Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene.

A Guide to a Pharmacist-Led Pharmacogenetic Testing and Counselling Service in an Interprofessional Healthcare Setting

Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report.

Methodological considerations on estimating medication adherence from self-report, electronic monitoring and electronic healthcare databases using the TEOS framework.

Delta T, a Useful Indicator for Pharmacy Dispensing Data to Monitor Medication Adherence

Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): study protocol for an open-label, randomized controlled trial.

Physicians’ Opinion Regarding Extended Access to Hormonal Contraception in Switzerland

Collaborators (8)

Noelia Amador-Fernández

Jacqueline Dunbar-Jacob

Kurt E Hersberger

Céline K Stäuble

Alexandra Lelia Dima

Markus L. Lampert

Monika Lutters

Henriette E. Meyer zu Schwabedissen

How do I reach out?

Meet Kite AI